小细胞肺癌患者早期死亡的风险因素:在SEER数据库中的回顾性研究
Zhenglin Li1, Min Pang1, Xuefeng Liang1
1The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences), Jinan, China.
Journal of cancer research and clinical oncology
|June 24, 2023
概括
这项研究确定了小细胞肺癌 (SCLC) 患者早期死亡的关键风险因素. 开发了一种预测性名谱,以帮助瘤学家个性化治疗,并改善高风险SCLC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 流行病学 流行病学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有快速死亡风险的侵袭性神经内分泌癌症.
- 早期死亡率,定义为生存时间不到一个月,在SCLC管理中构成了重大挑战.
研究的目的:
- 确定与SCLC患者早期死亡相关的关键风险因素.
- 开发和验证用于SCLC早期死亡的预测工具 (nomogram).
主要方法:
- 利用来自监测,流行病学和最终结果 (SEER) 数据库的27,163个SCLC病例 (2010-2019) 的数据.
- 使用单变量和多变量逻辑回归来确定重要的独立风险因素.
- 为预测所有原因和癌症特异性早期死亡而构建和评估名录.
主要成果:
- 确定年龄,性别,临床阶段,转移 (肝脏,肺) 和缺乏治疗 (手术,放射治疗,化疗) 作为早期死亡的重要预测因素.
- 开发的名图表显示出高准确度 (ROC曲线下的面积>0.850).
- 诺莫图显示出在预测早期死亡率方面具有潜在的临床效用.
结论:
- 已确定的关键因素与SCLC的早期死亡率有关.
- 为预测高风险SCLC患者开发了一种实用的名图.
- 诺米图可以帮助瘤学家量身定制治疗方法,以改善患者的治疗结果.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.2K
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Statistical Methods for Analyzing Epidemiological Data
426
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
426
Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
